ADD/ADHD News

Although stimulant dispensing rates have rebounded to — or exceeded — pre-pandemic levels among girls, the dispensing rate among adolescent boys was almost 19% lower than it was before March 2020, according to study findings.

Adults in the United Kingdom with an ADHD diagnosis appear to have shorter lifespans compared with the general population, likely due to unmet health support and treatment needs, according to a study in The British Journal of Psychiatry.

In a large network meta-analysis of pharmacological, psychological and neurostimulatory ADHD interventions, only stimulants and atomoxetine were associated with short-term reductions in core symptoms among adults.

Hundreds of millions of psychiatric disorders in the United States have been linked to childhood exposure of car exhaust from leaded gasoline, according to a recent study in the Journal of Child Psychology and Psychiatry.

Low-level lead poisoning remains prevalent across the United States and globally, warranting screening and identification of those at highest risk, according to a recently published review.

Researchers estimated that 6%, or one in 16, U.S. adults had an ADHD diagnosis, more than half of whom were diagnosed in adulthood, according to findings published in the CDC’s Morbidity and Mortality Weekly Report.

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a study published in JAMA Network Open.

Patients with past-month exposure to prescription amphetamines used to treat ADHD had higher odds of developing psychosis or mania compared with those without past-month exposure, according to a recent study.

The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.